PMID- 36792786 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230218 IS - 2191-219X (Print) IS - 2191-219X (Electronic) IS - 2191-219X (Linking) VI - 13 IP - 1 DP - 2023 Feb 15 TI - [(18)F] FDG uptake in patients with spondyloarthritis: correlation with serum inflammatory biomarker levels. PG - 15 LID - 10.1186/s13550-023-00964-9 [doi] LID - 15 AB - BACKGROUND: We aimed to evaluate the correlation between 2-deoxy-2-[(18)F]fluoro-D-glucose (FDG) uptake and disease activity assessed by serum inflammatory biomarker levels in patients with spondyloarthritis (SpA). METHODS: A total of 36 SpA patients (24 untreated and 12 treated) were examined using FDG positron emission tomography (PET)/computed tomography and classified into axial SpA (axSpA) and peripheral SpA (pSpA). FDG uptake was evaluated in 23 regions of the body and scored as follows: 0 = less than liver uptake; 1 = more than or equal to liver uptake; and 2 = more than or equal to twice liver uptake. A score of 1 or 2 was considered positive. The number of positive regions and the total score were counted in each patient. The maximum standardized uptake value (SUVmax) was calculated for each region, and maximum SUVmax (MaxSUVmax) was used as a representative value. Correlation of PET findings with serum inflammatory biomarker levels, including C-reactive protein (CRP), erythrocyte sedimentation rate, and matrix metalloproteinase 3 (MMP-3), was analyzed. RESULTS: All but two patients had at least one positive lesion. PET indices correlated significantly with most of the serum inflammatory biomarker levels in untreated SpA, but not in treated SpA. Further, MaxSUVmax, number of positive regions, and total score correlated significantly with CRP (all P values < 0.001), and the number of positive regions (P = 0.012) and total score (P = 0.007) correlated significantly with MMP-3 in untreated pSpA. PET indices did not correlate with any serum inflammatory biomarker level in untreated axSpA. CONCLUSION: FDG uptake in untreated pSpA correlated significantly with serum inflammatory biomarker levels. CI - (c) 2023. The Author(s). FAU - Manabe, Yuri AU - Manabe Y AUID- ORCID: 0000-0002-5286-157X AD - Department of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. manabe.yuri@kagawa-u.ac.jp. FAU - Norikane, Takashi AU - Norikane T AD - Department of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. FAU - Yamamoto, Yuka AU - Yamamoto Y AD - Department of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. FAU - Murao, Mitsumasa AU - Murao M AD - Department of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. FAU - Shimada, Hiromi AU - Shimada H AD - Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan. FAU - Wakiya, Risa AU - Wakiya R AD - Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan. FAU - Nakashima, Shusaku AU - Nakashima S AD - Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan. FAU - Dobashi, Hiroaki AU - Dobashi H AD - Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan. FAU - Nishiyama, Yoshihiro AU - Nishiyama Y AD - Department of Radiology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. LA - eng PT - Journal Article DEP - 20230215 PL - Germany TA - EJNMMI Res JT - EJNMMI research JID - 101560946 PMC - PMC9931986 OTO - NOTNLM OT - CRP OT - FDG OT - MMP-3 OT - PET OT - Spondyloarthritis COIS- The authors declare that they have no competing interests. EDAT- 2023/02/16 06:00 MHDA- 2023/02/16 06:01 PMCR- 2023/02/15 CRDT- 2023/02/15 23:25 PHST- 2022/12/14 00:00 [received] PHST- 2023/02/05 00:00 [accepted] PHST- 2023/02/15 23:25 [entrez] PHST- 2023/02/16 06:00 [pubmed] PHST- 2023/02/16 06:01 [medline] PHST- 2023/02/15 00:00 [pmc-release] AID - 10.1186/s13550-023-00964-9 [pii] AID - 964 [pii] AID - 10.1186/s13550-023-00964-9 [doi] PST - epublish SO - EJNMMI Res. 2023 Feb 15;13(1):15. doi: 10.1186/s13550-023-00964-9.